Advanced Search
- Cancer
- Chronic Diseases / Disorders
- Diabetes
- Diagnosis
- Fetal Alcohol Spectrum Disorder (FASD)
- Health Economics / Healthcare Costs
- Health Measurement Tools
- Health Policy
- Healthcare Services
- Infectious Diseases
- Maternal and Child Health
- Mental Health
- Other
- Pharmaceuticals
- Prevention
- Quality of Life
- Screening
- Surveillance
- Telehealth
- Therapy
- Brown, Jasmine
- Chojecki, Dagmara
- Corabian, Paula
- Escober-Doran, Carissa
- Guo, Bing
- Harstall, Christa
- Husereau, Don
- Institute of Health Economics, IHE
- Jacobs, Philip
- Jonsson, Egon
- Moga, Carmen
- Nguyen, Thanh
- Ohinmaa, Arto
- Scott, Ann
- Sproule, John
- Thompson, Angus
- Tjosvold, Lisa
- Waye, Arianna
- Yan, Charles
- Zheng, Yufei
Using Fetal Fibronectin to Diagnose Pre-term Labour
The role of rapid fetal fibronectin assay in the management of spontaneous preterm labour
The objective of this report is to evaluate the added value of using fetal fibronectin (Rapid fFN for the TLiTM System, referred to here as the rapid fFN assay) to diagnose spontaneous preterm labour (PTL) in symptomatic women, which is the only fFN detection modality currently available in Canada and the United States for this indication.
Information Specialist: Liz Dennett
Publication Type:
Health Technology Assessments /
Systematic Reviews
Year of Publication: 2008
Topics: Diagnosis, Maternal and Child Health
Authors: Paula Corabian, Christa Harstall
ISBN (print): 978-1-897443-13-2
ISBN (online): 978-1-897443-14-9
INAHTA URL: http://www.inahta.org/upload/Briefs_8/08045_IHE_Fetal_Fibronectin_PreTerm_Labor.pdf